The MTT assay is a widely used colorimetric method for evaluating the in vitro cytotoxicity of Traditional Chinese Medicine (TCM) extracts based on mitochondrial metabolic activity. This technical article provides a comprehensive overview of the assay principle, sample types, testing items, experimental methodology, applications, and frequently asked questions. It serves as a practical reference for pharmaceutical researchers, botanical drug developers, and quality control laboratories involved in herbal product safety evaluation.
Technical Overview
The MTT assay is a colorimetric test that quantifies cell viability by measuring the metabolic activity of living cells. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a yellow, water-soluble tetrazolium salt that penetrates viable cells and is reduced by NAD(P)H-dependent dehydrogenases and reductases in the mitochondria and cytoplasm to form insoluble purple formazan crystals. After the crystals are dissolved in a solubilization solvent such as DMSO or acidified isopropanol, the absorbance of the resulting solution is measured spectrophotometrically at 570 nm with a reference wavelength of 630-690 nm.
Because the amount of formazan produced is directly proportional to the number of metabolically active cells, the absorbance value reflects cell viability and proliferation status. In cytotoxicity testing of Traditional Chinese Medicine extracts, cells are exposed to a series of concentrations of the test extract, and the reduction in absorbance relative to untreated controls is used to calculate the cell inhibition rate and the half-maximal inhibitory concentration (IC50).
TCM extracts present unique analytical challenges, including intrinsic coloration, turbidity, and the presence of reducing compounds such as polyphenols that can chemically reduce MTT without cells. A well-designed MTT protocol for herbal samples therefore incorporates drug-only blank wells, solvent controls, and orthogonal confirmation assays to ensure that the measured signal reflects true biological activity rather than analytical interference.
Testing Samples
Crude Extracts of Single Herbs
Water decoction extracts, aqueous-ethanol extracts, and ethanol reflux extracts prepared from individual medicinal herbs. These extracts are typically concentrated and freeze-dried into powders, then redissolved in complete culture medium or DMSO as a stock solution before serial dilution.
Compound Formula Extracts
Extracts prepared from multi-herb prescriptions containing several botanical ingredients processed together. The chemical complexity of these samples is higher, and particular attention must be paid to solubility, precipitation upon dilution into aqueous medium, and blank correction.
Purified Fractions and Monomeric Compounds
Semi-purified fractions and single active constituents isolated from TCM materials, including alkaloids, flavonoids, glycosides, terpenoids, saponins, polysaccharides, and quinones. These samples generally provide cleaner analytical backgrounds and are commonly used in mechanistic cytotoxicity and antitumor screening studies.
Volatile Oils and Lipophilic Extracts
Essential oils and ether- or petroleum ether-soluble fractions. Due to poor water solubility, these samples require emulsification or low-level cosolvent systems, and the maximum achievable test concentration must be justified.
Finished Herbal Products
Herbal injections, oral liquids, concentrates, granules, dropping pills, and herbal-derived nanoparticles or liposomal formulations. Testing of finished products supports batch consistency evaluation and safety quality control.
Testing Items
The core measurable endpoints of the MTT cytotoxicity test for TCM extracts include:
- Cell viability rate at each test concentration and time point.
- Cell proliferation inhibition rate relative to the negative control group.
- Half-maximal inhibitory concentration (IC50) at 24, 48, and 72 hours.
- Dose-response and time-response relationship curves.
- Cytotoxicity grading according to relevant standards, such as ISO 10993-5, which classifies a sample as cytotoxic when cell viability falls below 70% of the blank control.
- Selectivity index (SI), defined as the ratio of IC50 values between normal cell lines and target tumor or pathological cell lines.
- Morphological observation of cells as supplementary qualitative evidence.
Testing Methods
A standard MTT cytotoxicity testing workflow for TCM extracts consists of the following steps:
- Cell line selection and culture: Commonly used tumor cell lines include HepG2, HCT-116, A549, MCF-7, HeLa, and SMMC-7721, while normal cell lines such as L-02, HEK293, Vero, and HUVEC are used for safety assessment. Cells are cultured in DMEM or RPMI-1640 medium supplemented with 10% fetal bovine serum at 37°C in a 5% CO2 incubator.
- Plate seeding: Cells in logarithmic growth phase are seeded into 96-well plates at a density of approximately 5,000 to 10,000 cells per well in 100 microliters of medium and allowed to adhere overnight.
- Drug treatment: The test extract is prepared as a sterile stock solution and serially diluted into 6 to 8 concentrations, typically covering three orders of magnitude. The final DMSO concentration in treatment wells should not exceed 0.1%. Treatment durations are typically 24, 48, and 72 hours.
- Control design: Each plate includes a blank well (medium only), a negative control well (cells plus vehicle), a positive control well (cells plus a known cytotoxin such as cisplatin, doxorubicin, or SDS), and drug-only blank wells (medium plus extract without cells) to correct for the intrinsic absorbance and reducing activity of colored herbal samples.
- MTT incubation: 10 to 20 microliters of MTT stock solution (5 mg/mL) is added to each well to reach a final concentration of about 0.5 mg/mL, followed by incubation for 3 to 4 hours at 37°C until visible formazan crystals form.
- Formazan dissolution: The culture medium is carefully removed, and 100 to 150 microliters of DMSO is added to each well. The plate is shaken on a microplate shaker for 5 to 10 minutes until all crystals are fully dissolved.
- Absorbance measurement: Optical density is read at 570 nm with a reference wavelength of 630 to 690 nm using a microplate reader.
- Data analysis: Cell viability is calculated as (OD treated minus OD drug blank) divided by (OD control minus OD blank) multiplied by 100%. Inhibition rate equals 100% minus viability. IC50 values are derived by nonlinear four-parameter logistic regression fitting of the dose-response curve.
- Acceptance criteria: The coefficient of variation among replicate wells should generally be below 15%, the positive control must produce the expected inhibition, and cell morphology should be consistent with the quantitative results.
For strongly colored or chemically reducing herbal samples, results should be confirmed with complementary methods such as the CCK-8/WST-1 assay, sulforhodamine B (SRB) staining, ATP-luminescence assays, flow cytometric apoptosis analysis, or direct cell counting, since MTT results can be confounded by non-enzymatic formazan formation.
Applications
MTT-based cytotoxicity testing of TCM extracts is applied across pharmaceutical research, development, and quality control:
- Antitumor lead discovery: Screening herbal extracts and isolated compounds for growth-inhibitory activity against human cancer cell lines and prioritizing candidates for in vivo evaluation.
- Safety evaluation: Assessing general cytotoxicity and potential hepatotoxicity or nephrotoxicity of herbal ingredients using normal parenchymal cell models before preclinical studies.
- Quality control: Comparing cytotoxicity profiles across batches of herbal injections and finished products to support batch consistency and safety release testing.
- Formulation development: Evaluating the safety of herbal nanoparticles, liposomes, self-emulsifying systems, and their excipients on cell viability.
- Herb-drug combination studies: Characterizing synergistic, additive, or antagonistic cytotoxic interactions between herbal extracts and conventional chemotherapeutic agents.
- Regulatory support: Providing in vitro cytotoxicity data packages for preclinical safety dossiers of botanical drug submissions.
FAQ
Why do colored TCM extracts interfere with MTT readings, and how is this corrected?
Many herbal extracts contain pigments, tannins, and polyphenols that absorb near 570 nm or chemically reduce MTT to formazan in the absence of cells. This is corrected by including drug-only blank wells for every concentration, subtracting their absorbance from the corresponding treated wells, and confirming key findings with an orthogonal viability method.
How is IC50 calculated and what does it indicate?
IC50 is the extract concentration that inhibits cell viability by 50% compared with the vehicle control. It is obtained by fitting the dose-response curve with a four-parameter logistic model. A lower IC50 indicates stronger cytotoxic or antiproliferative activity, while comparison of IC50 values between tumor and normal cells yields the selectivity index.
Which cell line should be selected for testing?
The choice depends on the study objective. Antitumor screening uses disease-relevant cancer cell lines, such as HepG2 for liver cancer or A549 for lung cancer. Safety-oriented studies should include normal human or animal cell lines, such as normal hepatocytes, HEK293, or Vero cells, to estimate the therapeutic window.
What are the differences between MTT, CCK-8, and SRB assays?
MTT forms an insoluble formazan that requires a dissolution step and kills the cells, making it an endpoint assay. CCK-8 uses a water-soluble tetrazolium salt and requires no dissolution step, enabling higher throughput. SRB stains cellular protein and measures total biomass rather than metabolic activity, making it less sensitive to metabolic interference from herbal compounds. Cross-validation between methods is recommended for complex herbal matrices.
What is the maximum allowable cosolvent concentration?
DMSO is the most common cosolvent for hydrophobic herbal compounds, and its final concentration in the culture well should not exceed 0.1%, because higher levels suppress cell viability and confound the cytotoxicity result. A vehicle control at the same final solvent concentration is mandatory.
What is the typical turnaround time for a complete test?
A standard test covering one sample, two or three cell lines, seven concentration levels, and three time points can typically be completed within 7 to 15 working days, including cell revival and passage, dosing, incubation, detection, and statistical analysis, provided the sample is received in a testable form with documented preparation information.